Volpara to supply cancer diagnostics SW to Intermountain Health

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software developer for breast cancer detection, which was acquired last May, signed a contract to supply breast cancer screening software to the US healthcare system Intermountain Health.

The products to be supplied include three of Volpara's flagship software: Risk Pathways, Analytics. and Scorecard.

These products will be used for cancer risk assessment, breast tissue density evaluation, and the improvement of mammography quality.

Intermountain Health is the largest nonprofit healthcare system in the western United States, operating 34 hospitals and over 400 clinics across seven states, including Utah, Idaho, and Nevada.

Write to Yoo-Rim Kim at youforest@hankyung.com